Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T
Calibr, a division of Scripps Research
Calibr, a division of Scripps Research
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
Gamida Cell ltd
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center
Prelude Therapeutics
Fred Hutchinson Cancer Center
Brown University
VA Office of Research and Development
Pfizer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Thomas Jefferson University
National Cancer Institute (NCI)
City of Hope Medical Center
Cedars-Sinai Medical Center
AbbVie
Ipsen
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Calibr, a division of Scripps Research
Mundipharma Research Limited
Kyowa Kirin Co., Ltd.
Pack Health
University College, London
City of Hope Medical Center
SCRI Development Innovations, LLC
Sumitomo Pharma America, Inc.
Children's Oncology Group
University of Pennsylvania
Duke University
Bristol-Myers Squibb
Fate Therapeutics
Karyopharm Therapeutics Inc
AbbVie
Uppsala University
University of Michigan Rogel Cancer Center
Duke University
National Institutes of Health Clinical Center (CC)
Northside Hospital, Inc.
Gamida Cell ltd
Jazz Pharmaceuticals